检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘敏娟[1] 孙静[1] 许云云[1] 臧志远[1] 刘柳[1] 张学光[1]
机构地区:[1]苏州大学医学生物技术研究所,江苏苏州215007
出 处:《苏州大学学报(医学版)》2010年第1期11-14,F0002,共5页Suzhou University Journal of Medical Science
基 金:国家自然科学基金资助项目(30571690)
摘 要:目的探讨体外建立健康人外周血B淋巴母细胞样细胞系(B-LCLs)的优化方法及其影响因素。方法用EB病毒感染健康人外周血中分离的单个核细胞(PBMC),加入CD40激发型抗体(5C11)、CpGDNA免疫调节基因序列以诱导B淋巴细胞增殖,环胞菌素A(CysA)抑制T淋巴细胞的活性。光学显微镜下观察B-LCLs的形态特征,利用流式细胞术分析B-LCLs膜表面分子CD19的表达水平。结果PBMC经EBV感染3周后转化成永生化B-LCLs。转化后的B淋巴母细胞体积增大积聚成团,可进一步分裂增殖并长期传代培养。CD40激发型抗体(5C11)及CpG免疫调节基因序列联合EBV感染人PBMC,明显地提高了转化效率,转化后的LCLs保持了成熟B淋巴细胞的生物学特征。结论CD40信号激发和CpG免疫调节基因序列联合运用能有效地促进EBV对人B淋巴细胞的转化及体外建系。Objective To explore optimized methods and the influencing factors of establishment of B lymphoblastoid cell lines(B-LCLs)derived from human PBMC in vitro.Methods The peripheral blood mononuclear cells(PBMCs)were isolated from healthy donors and incubated with EB virus(EBV)while agonist CD40mAb(5C11),CpG DNA motifs for stimulating B lymphocytes and cyclospofin A(CyA)for inhibiting T lymphocytes were added at the same time.Morphological characteristics of immortalized B-lymphocytes were observed under optical microscope.Flow cytometry analysis was used to identify the expression of surface molecule CD19 on B-LCLs.Results PBMCs incubated with EBV for 3 weeks were transformed into immortalized B-LCLs.These immortalized cells accumulated into groups and were able to be cultured into the long term proliferation.The agonist CD40mAb and CpG DNA motifs markedly promoted the EBV transformation process.EBV-immortalized B-LCLs maintained the biological features of mature B lymphocytes.Conclusion The combination of CD40 signal activation and CpG DNA motifs can effectively promote the EB virus transformation into human B lymphocytes and cell line establishment.
关 键 词:EB病毒 CpG免疫调节基因序列 CD40信号 B淋巴母细胞系
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:13.59.1.209